Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Illig

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Journal of Undergraduate Neuroscience Education : JUNE : a Publication of FUN, Faculty for Undergraduate Neuroscience|August 28, 2020
Faculty for Undergraduate Neuroscience (FUN) Statement on Diversity, Equity, and InclusionRonald J Bayline, Mary E Morrison, Kurt R Illig, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2016
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitorsSanath K Meegalla, Hui Huang, Carl R Illig, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitorsKenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitorsM Jonathan Rudolph, Carl R Illig, Nalin L Subasinghe, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|May 23, 2008
Structure-based optimization of a potent class of arylamide FMS inhibitorsSanath K Meegalla, Mark J Wall, Jinsheng Chen, et al.
Journal of Undergraduate Neuroscience Education : JUNE : a Publication of FUN, Faculty for Undergraduate Neuroscience|August 28, 2020
Faculty for Undergraduate Neuroscience (FUN) Statement on Diversity, Equity, and InclusionRonald J Bayline, Mary E Morrison, Kurt R Illig, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2016
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitorsSanath K Meegalla, Hui Huang, Carl R Illig, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Discovery of novel FMS kinase inhibitors as anti-inflammatory agentsCarl R Illig, Jinsheng Chen, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2010
Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitorsKenneth J Wilson, Carl R Illig, Jinsheng Chen, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.
Bioorganic & Medicinal Chemistry Letters|January 30, 2002
Design and synthesis of 4,5-disubstituted-thiophene-2-amidines as potent urokinase inhibitorsM Jonathan Rudolph, Carl R Illig, Nalin L Subasinghe, et al.
Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.
Pageof 11